Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3QHV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,212
Award facts
- Contract value 100% obligated
- $21,211.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $21,211.52 delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 2.5 mg/0.5 mL pen injections on December 2, 2025, with completion targeted for December 3, 2025. This is a firm fixed price order with no set-aside designation, competitively awarded through open procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical vendor supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's extensive federal contract portfolio demonstrates consistent capability to meet DLA procurement requirements through competitive awards. The Zepbound delivery order represents routine pharmaceutical procurement within the broader DLA Medical Supply Chain operations, which support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards involving at least three contractors, positioning AmerisourceBergen to continue serving critical military and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DR26F3QHV?
SPE2DR26F3QHV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F3QHV worth?
The government has obligated $21,212 on SPE2DR26F3QHV.
Is contract SPE2DR26F3QHV an order under another contract?
Yes. SPE2DR26F3QHV is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3QHV competed?
The extent of competition for SPE2DR26F3QHV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award